Email this article 
Etiology and treatment of circumscribed sclerodermarevisited
- Authors: Dvornikov AS1, Kruglova LS1, Dvornikov AS1, Kruglova LS1
-
Affiliations:
- Issue: Vol 86, No 6 (2010)
- Pages: 101-106
- Section: Articles
- Submitted: 11.03.2020
- Published: 15.12.2010
- URL: https://vestnikdv.ru/jour/article/view/842
- DOI: https://doi.org/10.25208/vdv842
- ID: 842
Cite item
Full Text
Abstract
There was a clinical and laboratory study of the efficacy of complex treatment with Longidaza, a Russian enzyme drug, in 30
patients suffering from circumscribed scleroderma. High efficacy of treatment for different clinical forms of circumscribed scleroderma
using this method was proved. A positive effect of the complex therapy on the results of ultrasonic skin examination in the
affection foci and individual blood immunology indices was revealed.
patients suffering from circumscribed scleroderma. High efficacy of treatment for different clinical forms of circumscribed scleroderma
using this method was proved. A positive effect of the complex therapy on the results of ultrasonic skin examination in the
affection foci and individual blood immunology indices was revealed.
Keywords
About the authors
A S Dvornikov
Email: zam@kvkd1.ru
L S Kruglova
Email: zam@kvkd1.ru
A S Dvornikov
L S Kruglova
References
- Кубанова А.А., Тихонова Л.И. Дерматовенерология в России. Реальность и перспективы. Вест.дерматол. и венерол. 2004; 2: 4-11.
- Коробейникова Э.А., Мартынова Л.М., Анисимова А.В. Кли- нические аспекты ограниченной склеродермии. Рос. журн. кожн. и венерич. болезней, 2004; 3: 27-29.
- Караулов А.В. Клиническая иммунология и аллергология. М.: Медицина, 2002; 238-269.
- Довжанский С.И. Клинико-иммунологические параллели при ограниченной и системной склеродермии. Рос. журн. кожн. и венерич. болезней, 2002; 4: 26-29.
- Wenzel J. Scleroderma and malignancy. Mechanisms of interrelationship. Eur J Dermatol 2002; 12 (3): 296-300.
- Sellheyer K., Krahl D. Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms. J Cutan Pathol 2008; 35(4): 366-372.
- Kaji K., Fujimoto M., Hasegawa M. et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007; 46 (1): 25-28.
- Billet S.E., Grando S.A., Pittelkow M.R. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 2006; 39 (7): 617-630.
- Gunawardena H., Wedderburn L.R., North J. et al. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford) 2008; 47 (3): 324-328.
- Heymann W.R. Paraneoplastic autoimmune multiorgan syndrome. J Am Acad Dermatol 2004; 51 (4): 631-632.
- Moore R.L., Devere T.S. Epidermal manifestations of internal malignancy. Dermatol Clin 2008; 26 (1): 17-29.
- Garcia-Rio I., Delgado-Jimenez Y., Alonso-Perez A. et al. Radiationinduced morphea. J Eur Acad Dermatol Venereol 2003; 17 (3): 6-24.
- Tournillac I., Dandurand M., Guillot B. Bullous lichen sclerosus after radiotherapy. Ann Dermatol Venereol 1998; 125 (2): 121-123.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).